Zhanzhan Xu

机构：Peking University, Soochow University, Peking University Cancer Hospital

发表论文 24 篇 · 总被引 374 次 · h-index 10

代表论文

• Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis (2016 · Medical Oncology · 被引 93)
• RETRACTED: Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods (2024 · International Journal of Biological Macromolecules · 被引 58)
• The landscape of hervRNAs transcribed from human endogenous retroviruses across human body sites (2022 · Genome biology · 被引 47)
• LC8/DYNLL1 is a 53BP1 effector and regulates checkpoint activation (2019 · Nucleic Acids Research · 被引 45)
• Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA (2020 · Oncogene · 被引 43)
• Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells (2015 · International Journal of Oncology · 被引 25)